Drug Shortage Report for RAN-IRBESARTAN

Last updated on 2019-02-01 History
Report ID 31228
Drug Identification Number 02406829
Brand name RAN-IRBESARTAN
Common or Proper name RAN-IRBESARTAN
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) IRBESARTAN
Strength(s) 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-11-30
Actual start date 2017-11-30
Estimated end date 2018-03-15
Actual end date 2017-12-04
Shortage status Resolved
Updated date 2019-02-01
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-02-01 French Compare
v10 2019-02-01 English Compare
v9 2017-12-15 French Compare
v8 2017-12-15 English Compare
v7 2017-12-01 English Compare
v6 2017-11-30 French Compare
v5 2017-11-30 English Compare
v4 2017-11-30 French Compare
v3 2017-11-30 English Compare
v2 2017-11-30 French Compare
v1 2017-11-30 English Compare